Search research articles
Contact Us
Filters
Showing results (301-310 of 363) with videos related to
Page
of 37
Sort By:
The Journal of Infectious Diseases
|
November 1, 1995
Primary structure of the V3 region of gp120 from sequential human immunodeficiency virus type 1 isolates obtained from patients from the time of seroconversion
O Distler, P W McQueen, M L Tsang, et al.
The Journal of Infectious Diseases
|
February 22, 2001
Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection
J J Zaunders, G R Kaufmann, P H Cunningham, et al.
HIV Medicine
|
December 12, 2001
Therapeutic vaccination (p24-VLP) of patients with advanced HIV-1 infection in the pre-HAART era does not alter CD4 cell decline
D Smith, I Gow, R Colebunders, et al.
The Journal of Infectious Diseases
|
May 1, 1996
Changes in biologic phenotype of human immunodeficiency virus during treatment of patients with didanosine
N N Zheng, P W McQueen, L Hurren, et al.
AIDS (London, England)
|
August 1, 1992
The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex
C Pedersen, D A Cooper, F Brun-Vézinet, et al.
AIDS (London, England)
|
March 1, 1994
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)
J W Mulder, D A Cooper, L Mathiesen, et al.
HIV Medicine
|
May 24, 2011
Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)
E R Feeney, C Chazallon, N O'Brien, et al.
The Journal of Nutrition
|
April 16, 1999
Demographic, dietary and lifestyle factors differentially explain variability in serum carotenoids and fat-soluble vitamins: baseline results from the sentinel site of the Olestra Post-Marketing Surveillance Study
C L Rock, M D Thornquist, A R Kristal, et al.
AIDS (London, England)
|
August 1, 1991
The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative Group
D A Cooper, C Pedersen, F Aiuti, et al.
The Journal of Nutrition
|
March 7, 2000
Olestra consumption is not associated with macular pigment optical density in a cross-sectional volunteer sample in Indianapolis
D A Cooper, J Curran-Celentano, T A Ciulla, et al.
Page
of 37
Search research articles
Search
Showing results (301-310 of 363) with videos related to
Sort By:
Page
of 37
The Journal of Infectious Diseases
|
November 1, 1995
Primary structure of the V3 region of gp120 from sequential human immunodeficiency virus type 1 isolates obtained from patients from the time of seroconversion
O Distler, P W McQueen, M L Tsang, et al.
The Journal of Infectious Diseases
|
February 22, 2001
Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection
J J Zaunders, G R Kaufmann, P H Cunningham, et al.
HIV Medicine
|
December 12, 2001
Therapeutic vaccination (p24-VLP) of patients with advanced HIV-1 infection in the pre-HAART era does not alter CD4 cell decline
D Smith, I Gow, R Colebunders, et al.
The Journal of Infectious Diseases
|
May 1, 1996
Changes in biologic phenotype of human immunodeficiency virus during treatment of patients with didanosine
N N Zheng, P W McQueen, L Hurren, et al.
AIDS (London, England)
|
August 1, 1992
The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex
C Pedersen, D A Cooper, F Brun-Vézinet, et al.
AIDS (London, England)
|
March 1, 1994
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)
J W Mulder, D A Cooper, L Mathiesen, et al.
HIV Medicine
|
May 24, 2011
Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)
E R Feeney, C Chazallon, N O'Brien, et al.
The Journal of Nutrition
|
April 16, 1999
Demographic, dietary and lifestyle factors differentially explain variability in serum carotenoids and fat-soluble vitamins: baseline results from the sentinel site of the Olestra Post-Marketing Surveillance Study
C L Rock, M D Thornquist, A R Kristal, et al.
AIDS (London, England)
|
August 1, 1991
The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative Group
D A Cooper, C Pedersen, F Aiuti, et al.
The Journal of Nutrition
|
March 7, 2000
Olestra consumption is not associated with macular pigment optical density in a cross-sectional volunteer sample in Indianapolis
D A Cooper, J Curran-Celentano, T A Ciulla, et al.
Page
of 37